A Stewardship Program’s Retrospective Evaluation of Vancomycin AUC24/MIC and Time to Microbiological Clearance in Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia and Osteomyelitis-Reference-Cited by-同舟云学术

A Stewardship Program’s Retrospective Evaluation of Vancomycin AUC24/MIC and Time to Microbiological Clearance in Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia and Osteomyelitis

Published:2013-06 Issue:6 Volume:35 Page:772-779
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Gawronski Kristen M.,Goff Debra A.,Jack Brown ,Khadem Tina M.,Bauer Karri A.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference29 articles.

1. Predictors of mortality for methicillin-resistant Staphylococcus aureus health-care-associated pneumonia: specific evaluation of vancomycin pharmacokinetic indices;Jeffres;Chest,2006

2. Clinical features of heteroresistant vancomycin-intermediate Staphylococcus aureus bacteremia versus those of methicillin-resistant S. aureus bacteremia;Maor;J Infect Dis,2009

3. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2003, issued August 2003. Am J Infect Control. 2003;31:481–498

4. Molecular epidemiology of methicillin-resistant Staphylococcus aureus bloodstream isolates in urban Detroit;Chua;J Clin Microbiol,2008

5. Burden of methicillin-resistant Staphylococcus aureus: focus on clinical and economic outcomes;Lodise;Pharmacotherapy,2007

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of target area under the concentration–time curve of vancomycin in an initial dosing design: a retrospective cohort study;Journal of Antimicrobial Chemotherapy;2024-07-19

2. Predictive Value of Vancomycin AUC24/MIC Ratio for 30-day Mortality in Patients with Severe or Complicated Methicillin-Resistant Staphylococcus aureus Infections: A Multicenter Retrospective Study;Pharmaceutical Research;2024-06-17

3. Is It Still Beneficial to Monitor the Trough Concentration of Vancomycin? A Quantitative Meta-Analysis of Nephrotoxicity and Efficacy;Antibiotics;2024-05-28

4. Serum concentration of continuously administered vancomycin influences efficacy and safety in critically ill adults: a systematic review;International Journal of Antimicrobial Agents;2023-12

5. Contemporary pharmacologic treatments of MRSA for hospitalized adults: rationale for vancomycin versus non-vancomycin therapies as first line agents;Expert Review of Anti-infective Therapy;2023-11-02